Tilray Executive and Leadership Team

Armando Fumanelli, the Chief Executive Officer at Tilray, directs the company's overarching strategic vision and operational execution. Fumanelli oversees all major business units, ensuring alignment with market demands and long-term growth objectives. This leadership role involves driving innovation in the medical cannabis sector, focusing on research, cultivation, and distribution advancements. By optimizing resource allocation and fostering cross-departmental collaboration, Fumanelli ensures Tilray maintains its competitive edge. The Chief Executive Officer's mandate includes expanding market reach and enhancing product development pipelines. Fumanelli's strategic direction guides the company's expansion into new territories and product categories, solidifying Tilray's position as a leader in the global cannabinoid market. Armando Fumanelli's leadership is critical for navigating complex regulatory landscapes and capitalizing on emerging opportunities within the pharmaceutical and wellness industries.

Irwin Simon, the Chairman & Chief Executive Officer at Tilray, steers the company's strategic direction and corporate governance. Simon's leadership encompasses guiding Tilray's expansion in the medical cannabis and cannabinoid markets, emphasizing research, cultivation, and distribution excellence. This executive role involves fostering key stakeholder relationships and ensuring robust financial performance. By championing product innovation and market penetration strategies, Simon drives Tilray's global impact. The Chairman & Chief Executive Officer's responsibilities include overseeing the integration of new business ventures and maintaining high standards of operational efficiency. Irwin Simon's vision is instrumental in positioning Tilray as a premier entity within the pharmaceutical and wellness sectors, navigating regulatory frameworks and seizing growth opportunities across international markets. Simon's influence extends to shaping the company's culture and long-term sustainability.

Sebastien St-Louis, the Founder, President & Chief Executive Officer at Tilray, establishes the foundational vision and drives the company's strategic initiatives. St-Louis oversees the comprehensive lifecycle of medical cannabis and cannabinoid products, from initial research and cultivation to production and global distribution. This executive position involves leading innovation efforts and ensuring adherence to stringent quality and regulatory standards. By championing advancements in cultivation techniques and product development, St-Louis enhances Tilray's market leadership. The Founder, President & Chief Executive Officer's mandate includes fostering strategic partnerships and expanding the company's operational footprint. Sebastien St-Louis's entrepreneurial spirit guides Tilray's mission to improve patient outcomes through high-quality cannabinoid therapies. St-Louis's commitment to scientific rigor and market expansion solidifies Tilray's reputation in the pharmaceutical industry.

Carl Merton, the Chief Financial Officer at Tilray, directs all financial operations and strategic fiscal planning. Merton oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health and compliance across the organization. This executive role involves managing capital allocation, optimizing financial performance, and mitigating financial risks associated with global operations. By implementing sound financial strategies, Merton supports Tilray's research, cultivation, and distribution initiatives. The Chief Financial Officer's responsibilities include driving profitability and ensuring sustainable growth in the competitive medical cannabis market. Carl Merton's expertise is crucial for securing investment, managing investor relations, and maintaining the financial integrity of Tilray's expanding business. Merton's financial acumen underpins the company's ability to pursue strategic acquisitions and market expansions.

Thomas Adams, the Interim Chief Financial Officer, Tilray Beer at Tilray, provides critical financial oversight for the company's beverage division. Adams manages the financial health of Tilray Beer, focusing on budgeting, financial analysis, and strategic planning to support growth and profitability within this specific market segment. This executive role involves ensuring accurate financial reporting and compliance with industry-specific regulations. By optimizing financial processes and resource allocation, Adams drives efficiency and supports the expansion of Tilray Beer's product lines. The Interim Chief Financial Officer's responsibilities include evaluating investment opportunities and managing financial risks unique to the beverage industry. Thomas Adams's financial expertise is vital for the successful integration and performance of the Tilray Beer operations, contributing to the overall financial strength of the parent company. Adams ensures sound financial management for this key business unit.

Blair MacNeil, the President, Canada at Tilray, leads the company's strategic operations and market development within the Canadian region. MacNeil oversees all aspects of Tilray's business in Canada, including cultivation, production, and distribution of medical cannabis and cannabinoid products, ensuring alignment with national regulations and market demands. This executive position involves driving regional growth, managing key stakeholder relationships, and optimizing operational performance across Canadian facilities. By championing local market strategies and fostering strong distribution networks, MacNeil enhances Tilray's presence and impact in its home market. The President, Canada's responsibilities include spearheading new product introductions and expanding market share within the Canadian pharmaceutical and wellness sectors. Blair MacNeil's leadership is pivotal for navigating the specific regulatory and commercial landscape of Canada, contributing significantly to Tilray's global success. MacNeil ensures robust operations and market penetration in Canada.

Lloyd Brathwaite, the Chief Information Officer at Tilray, architects and manages the company's entire technology infrastructure and digital strategy. Brathwaite oversees the implementation of advanced IT systems that support Tilray's complex operations in research, cultivation, production, and distribution of medical cannabis and cannabinoids. This leadership position involves ensuring data security, optimizing network performance, and driving digital transformation initiatives across all departments. By leveraging cutting-edge technology, Brathwaite enhances operational efficiency and supports data-driven decision-making. The Chief Information Officer's mandate includes developing scalable IT solutions that accommodate global expansion and evolving market demands. Lloyd Brathwaite's strategic technology vision is essential for maintaining Tilray's competitive advantage and ensuring seamless integration of new digital tools and platforms. Brathwaite's focus on innovation empowers the company's scientific and commercial teams.

Roger Savell, the Chief Administrative Officer at Tilray, directs the company's essential administrative functions and operational support services. Savell oversees human resources, legal affairs, and corporate governance, ensuring efficient and compliant business operations across all divisions. This executive role involves managing organizational policies, optimizing internal processes, and fostering a productive work environment that supports Tilray's mission in medical cannabis and cannabinoids. By streamlining administrative procedures and enhancing employee support systems, Savell contributes to overall operational excellence. The Chief Administrative Officer's mandate includes ensuring seamless integration of administrative functions during periods of growth and expansion. Roger Savell's leadership is critical for maintaining the organizational infrastructure that underpins Tilray's research, cultivation, and distribution efforts. Savell's focus on operational efficiency supports the company's strategic objectives.